The 12 most recent market catalysts affecting $ADUS, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 16, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Lifts Price Target on Addus HomeCare to $141 From $134
RBC Capital Markets has raised its price target for Addus HomeCare (ADUS) from $134 to $141, while reiterating an 'Outperform' rating. This analyst upgrade signals increased confid…
Nov 12, 2026
Corporate Catalyst
Neutral
Impact 65
Addus HomeCare Officer Executes $12.2 Million Stock Sale
An officer at Addus HomeCare Corporation executed a significant sale of 99,000 shares, valued at approximately $12.2 million. This transaction is noteworthy because large insider s…
Nov 10, 2026
Corporate Catalyst
Neutral
Impact 65
Addus HomeCare Insider Sells Shares Worth $12,198,991
An insider at Addus HomeCare Corporation (ADUS) sold over $12 million worth of company stock, a substantial transaction reported via an SEC filing. This event is significant becaus…
Nov 5, 2026
Corporate Catalyst
Bullish
Impact 65
TD Cowen Raises Price Target on Addus HomeCare to $145
TD Cowen has raised its price target for Addus HomeCare (ADUS) to $145, up from $131, and reiterated its 'Buy' rating. This analyst action signals increased confidence in ADUS's va…
Nov 5, 2026
Corporate Catalyst
Bullish
Impact 65
UBS Raises Price Target on Addus HomeCare to $160
UBS has raised its price target on Addus HomeCare (ADUS) to $160 from $145, maintaining its 'Buy' rating. This upgrade is a direct result of the firm's updated assessment following…
Nov 5, 2026
Corporate Catalyst
Bullish
Impact 55
Truist Raises Price Target on Addus HomeCare to $148 From $135, Keeps Buy Rating
Truist Financial has raised its price target for Addus HomeCare (ADUS) from $135 to $148 and maintained its 'Buy' rating. This upgrade comes after the company's third-quarter 2026 …
Nov 4, 2026
Corporate Catalyst
Bullish
Impact 55
Barclays Adjusts Price Target for Addus HomeCare
Barclays updated its outlook on Addus HomeCare, raising its price target to $101 from $96. Despite this increase, the firm maintained its 'Underweight' rating, which is a key signa…
Nov 4, 2026
Corporate Catalyst
Bullish
Impact 55
Addus HomeCare Corporation Analyst Price Target Increased
Analysts have slightly raised their average 12-month price target for Addus HomeCare Corporation (ADUS) from $134.08 to $134.92. This modest increase, coupled with a maintained 'Bu…
Sep 14, 2026
Corporate Catalyst
Bearish
Impact 65
B of A Securities Downgrades Addus HomeCare to Neutral, Lowers Price Target to $125
B of A Securities analyst Joanna Gajuk downgraded Addus HomeCare (ADUS) from a 'Buy' rating to 'Neutral' and simultaneously lowered the price target from $140 to $125. This action …
Aug 10, 2026
Corporate Catalyst
Neutral
Impact 75
Addus HomeCare Announces That Heather Dixon, President And Chief Operating Officer, Is No Longer With The Company; Brad Bickham, Former President And COO At Addus, Has Agreed To Return As COO On An Interim Basis, Effective Immediately
Addus HomeCare announced a significant leadership change with the departure of Heather Dixon, President and Chief Operating Officer. This is a notable event as the COO role is crit…
Aug 5, 2026
Corporate Catalyst
Bullish
Impact 55
RBC Capital Maintains Outperform on Addus HomeCare, Raises Price Target to $134
RBC Capital's analyst Ben Hendrix maintained an 'Outperform' rating on Addus HomeCare (ADUS) and raised the price target from $130 to $134. This action signals continued confidence…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.